Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2026-01-16 @ 5:59 AM
Study NCT ID:
NCT00755118
Status:
TERMINATED
Last Update Posted:
2015-10-07
First Post:
2008-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
Sponsor:
University Hospital of Crete
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CT/08.28
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None